2020
Differences in maternal group B Streptococcus screening rates in Latin American countries
HogenEsch E, De Mucio B, Haddad LB, Vilajeliu A, Ropero AM, Yildirim I, Omer SB. Differences in maternal group B Streptococcus screening rates in Latin American countries. Vaccine 2020, 39: b3-b11. PMID: 33308886, DOI: 10.1016/j.vaccine.2020.10.082.Peer-Reviewed Original ResearchConceptsMaternal GBS screeningMaternal GBS colonizationGBS screeningGBS colonizationScreening ratesPregnant womenGroup B Streptococcus ScreeningMaternal group B StreptococcusLogistic regressionGBS colonization prevalenceIntrapartum antibiotic treatmentMaternal GBS vaccineNeonatal GBS diseaseAdverse neonatal outcomesRetrospective observational studyMaternal age groupsGroup B streptococciDemographic variablesLower ratesGBS prevalenceFinal regression modelGBS diseaseNeonatal outcomesNeonatal sepsisGBS vaccine
2019
3162 Colonization of Pregnant Women with Group B streptococcus in Latin America and Infant Outcomes
HogenEsch E, Haddad L, Yildirim I, Omer S. 3162 Colonization of Pregnant Women with Group B streptococcus in Latin America and Infant Outcomes. Journal Of Clinical And Translational Science 2019, 3: 37-38. PMCID: PMC6808231, DOI: 10.1017/cts.2019.92.Peer-Reviewed Original ResearchMaternal GBS colonizationGBS colonizationPreterm birthCesarean sectionPregnant womenRisk factorsGBS diseasePerinatal outcomesMaternal colonizationPrevalence ratesExact testSignificant associationMultiple logistic regression modelBurden of stillbirthsGBS colonization statusGBS-negative mothersGBS-positive mothersMaternal GBS carriageNeonatal GBS diseasePerinatal health indicatorsSpecific perinatal outcomesIncidence of sepsisClinical risk factorsWeeks of gestationGroup B streptococci